Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1

eLife

Volumn 3, Issue , 2014, Pages 1-18

  Chen, Guo Yun ^a   Brown, Nicholas K ^a   Wu, Wei ^a   Khedri, Zahra ^b   Yu, Hai ^b   Chen, Xi ^b   van de Vlekkert, Diantha ^c   D'Azzo, Alessandra ^c   Zheng, Pan ^a   Liu, Yang ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LECTIN RECEPTOR; PATTERN RECOGNITION RECEPTOR; RECOMBINANT PROTEIN; SIALIC ACID BINDING IMMUNOGLOBULIN SUPERFAMILY LECTIN RECEPTOR; SIALIDASE; SIALIDASE INHIBITOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; B LYMPHOCYTE ANTIGEN; CYTOKINE; ENZYME INHIBITOR; ISOPROTEIN; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; NEU1 PROTEIN, MOUSE; OLIGODEOXYRIBONUCLEOTIDE; PROTEIN BINDING; SIGLECE PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE MUTATION; IMMUNOPRECIPITATION; INFLAMMATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; 129 MOUSE; ANIMAL; C57BL MOUSE; CELL LINE; DENDRITIC CELL; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL LINE; CYTOKINES; DENDRITIC CELLS; ENDOTOXEMIA; ENZYME INHIBITORS; HUMANS; IMMUNOBLOTTING; LIPOPOLYSACCHARIDES; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; NEURAMINIDASE; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, PATTERN RECOGNITION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 4;

EID: 84924588111     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/elife.04066     Document Type: Article

References (51)

1. Abdulkhalek S, Amith SR, Franchuk SL, Jayanth P, Guo M, Finlay T, Gilmour A, Guzzo C, Gee K, Beyaert R, Szewczuk MR. 2011. Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling. The Journal of Biological Chemistry 286: 36532-36549. doi: 10. 1074/jbc. M111. 237578.
2. Amith SR, Jayanth P, Franchuk S, Finlay T, Seyrantepe V, Beyaert R, Pshezhetsky AV, Szewczuk MR. 2010. Neu1 desialylation of sialyl alpha-2, 3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Cellular Signalling 22: 314-324. doi: 10. 1016/j. cellsig. 2009. 09. 038.
3. Amith SR, Jayanth P, Franchuk S, Siddiqui S, Seyrantepe V, Gee K, Basta S, Beyaert R, Pshezhetsky AV, Szewczuk MR. 2009. Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase. Glycoconjugate Journal 26: 1197-1212. doi: 10. 1007/s10719-009-9239-8.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 29: 1303-1310. doi: 10. 1097/00003246-200107000-00002.
5. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, André F, Delaloge S, Tursz T, Kroemer G, Zitvogel L. 2007. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Medicine 13: 1050-1059. doi: 10. 1038/nm1622.
6. Bachmann MF, Lutz MB, Layton GT, Harris SJ, Fehr T, Rescigno M, Ricciardi-Castagnoli P. 1996. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. European Journal of Immunology 26: 2595-2600. doi: 10. 1002/eji. 1830261109.
7. Bandala-Sanchez E, Zhang Y, Reinwald S, Dromey JA, Lee BH, Qian J, Bohmer RM, Harrison LC. 2013. T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10. Nature Immunology 14: 741-748. doi: 10. 1038/ni. 2610.
8. Boyd CR, Orr SJ, Spence S, Burrows JF, Elliott J, Carroll HP, Brennan K, Ni Gabhann J, Coulter WA, Jones C, Crocker PR, Johnston JA, Jefferies CA. 2009. Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production. The Journal of Immunology 183: 7703-7709. doi: 10. 4049/jimmunol. 0902780.
9. Broz P, Ruby T, Belhocine K, Bouley DM, Kayagaki N, Dixit VM, Monack DM. 2012. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490: 288-291. doi: 10. 1038/nature11419.
10. Chang YC, Olson J, Beasley FC, Tung C, Zhang J, Crocker PR, Varki A, Nizet V. 2014. Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo. PLOS Pathogens 10: e1003846. doi: 10. 1371/journal. ppat. 1003846.
11. Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Zheng P. 2008. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. The Journal of Experimental Medicine 205: 2397-2408. doi: 10. 1084/jem. 20081297.
12. Chen GY, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, Wu W, Bai XF, Liu JQ, Woodiga SA, Chen C, Sun L, Hogaboam CM, Kunkel SL, Zheng P, Liu Y. 2011. Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nature Biotechnology 29: 428-435. doi: 10. 1038/nbt. 1846.
13. Chen GY, Tang J, Zheng P, Liu Y. 2009. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323: 1722-1725. doi: 10. 1126/science. 1168988.
14. Chen W, Han C, Xie B, Hu X, Yu Q, Shi L, Wang Q, Li D, Wang J, Zheng P, Liu Y, Cao X. 2013. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 152: 467-478. doi: 10. 1016/j. cell. 2013. 01. 011.
15. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. Nature Reviews Immunology 7: 255-266. doi: 10. 1038/nri2056.
16. de Geest N, Bonten E, Mann L, de Sousa-Hitzler J, Hahn C, d'Azzo A. 2002. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Human Molecular Genetics 11: 1455-1464. doi: 10. 1093/hmg/11. 12. 1455.
17. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. 2007. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Critical Care Medicine 35: 1244-1250. doi: 10. 1097/01. CCM. 0000261890. 41311. E9.
18. Duong BH, Tian H, Ota T, Completo G, Han S, Vela JL, Ota M, Kubitz M, Bovin N, Paulson JC, Nemazee D. 2010. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. The Journal of Experimental Medicine 207: 173-187. doi: 10. 1084/jem. 20091873.
19. Franchi L, Munoz-Planillo R, Nunez G. 2012. Sensing and reacting to microbes through the inflammasomes. Nature Immunology 13: 325-332. doi: 10. 1038/ni. 2231.
20. Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K, Shibuya M, Akira S, Aburatani H, Maru Y. 2008. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nature Cell Biology 10: 1349-1355. doi: 10. 1038/ncb1794.
21. Hurley JC. 1995. Endotoxemia: methods of detection and clinical correlates. Clinical Microbiology Reviews 8: 268-292.
22. Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, Musco G, Sitia G, Yap GS, Wan Y, Biron CA, Bianchi ME, Wang H, Chu WM. 2007. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110: 1970-1981. doi: 10. 1182/blood-2006-09-044776.
23. Janeway CA. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symposia on Quantitative Biology 54: 1-13. doi: 10. 1101/SQB. 1989. 054. 01. 003.
24. Janeway CA Jnr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunology today 13: 11-16. doi: 10. 1016/0167-5699(92)90198-G.
25. Jellusova J, Wellmann U, Amann K, Winkler TH, Nitschke L. 2010. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. Journal of Immunology 184: 3618-3627. doi: 10. 4049/jimmunol. 0902711.
26. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology 11: 373-384. doi: 10. 1038/ni. 1863.
27. Li Y, Cao H, Yu H, Chen Y, Lau K, Qu J, Thon V, Sugiarto G, Chen X. 2011. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies. Molecular Biosystems 7: 1060-1072. doi: 10. 1039/c0mb00244e.
28. Li Y, Yu H, Cao H, Lau K, Muthana S, Tiwari VK, Son B, Chen X. 2008. Pasteurella multocida sialic acid aldolase: a promising biocatalyst. Applied Microbiology and Biotechnology 79: 963-970. doi: 10. 1007/s00253-008-1506-2.
29. Liang F, Seyrantepe V, Landry K, Ahmad R, Ahmad A, Stamatos NM, Pshezhetsky AV. 2006. Monocyte differentiation up-regulates the expression of the lysosomal sialidase, Neu1, and triggers its targeting to the plasma membrane via major histocompatibility complex class II-positive compartments. The Journal of Biological Chemistry 281: 27526-27538. doi: 10. 1074/jbc. M605633200.
30. Liu X, Fagotto F. 2011. A method to separate nuclear, cytosolic, and membrane-associated signaling molecules in cultured cells. Science Signaling 4: pl2. doi: 10. 1126/scisignal. 2002373.
31. Liu Y, Chen GY, Zheng P. 2009. CD24-Siglec G/10 discriminates danger-from pathogen-associated molecular patterns. Trends in Immunology 30: 557-561. doi: 10. 1016/j. it. 2009. 09. 006.
32. Liu Y, Janeway CA Jnr. 1991. Microbial induction of co-stimulatory activity for CD4 T-cell growth. International Immunology 3: 323-332. doi: 10. 1093/intimm/3. 4. 323.
33. Liu Y, Janeway CA Jnr. 1992. Cells that present both specific ligand and the costimulatory activity are the most efficient inducer of clonal expansion of normal CD4 T cells. Proceedings of the National Academy of Sciences of USA 89: 3845-3849. doi: 10. 1073/pnas. 89. 9. 3845.
34. Matzinger P. 1994. Tolerance, danger, and the extended family. Annual Review of Immunology 12: 991-1045. doi: 10. 1146/annurev. iy. 12. 040194. 005015.
35. McMillan SJ, Sharma RS, McKenzie EJ, Richards HE, Zhang J, Prescott A, Crocker PR. 2013. Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b beta2-integrin-dependent signaling. Blood 121: 2084-2094. doi: 10. 1182/blood-2012-08-449983.
36. Medzhitov R, Preston-Hurlburt P, Janeway CA Jnr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397. doi: 10. 1038/41131.
37. Millar DG, Garza KM, Odermatt B, Elford AR, Ono N, Li Z, Ohashi PS. 2003. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nature Medicine 9: 1469-1476. doi: 10. 1038/nm962.
38. Miyagi T, Yamaguchi K. 2012. Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology 22: 880-896. doi: 10. 1093/glycob/cws057.
39. Pfrengle F, Macauley MS, Kawasaki N, Paulson JC. 2013. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22. Journal of Immunology 191: 1724-1731. doi: 10. 4049/jimmunol. 1300921.
40. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088. doi: 10. 1126/science. 282. 5396. 2085.
41. Seppo A, Matani P, Sharrow M, Tiemeyer M. 2003. Induction of neuron-specific glycosylation by Tollo/Toll-8, a Drosophila Toll-like receptor expressed in non-neural cells. Development 130: 1439-1448. doi: 10. 1242/dev. 00347.
42. Seyrantepe V, Poupetova H, Froissart R, Zabot MT, Maire I, Pshezhetsky AV. 2003. Molecular pathology of NEU1 gene in sialidosis. Human Mutation 22: 343-352. doi: 10. 1002/humu. 10268.
43. Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T. 1991. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell 66: 1133-1144. doi: 10. 1016/0092-8674(91)90036-X.
44. Takahashi K, Fukushima S, Yamahara K, Yashiro K, Shintani Y, Coppen SR, Salem HK, Brouilette SW, Yacoub MH, Suzuki K. 2008. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation 118: S106-S114. doi: 10. 1161/CIRCULATIONAHA. 107. 757443.
45. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ. 2007. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nature Immunology 8: 487-496. doi: 10. 1038/ni1457.
46. Ting JP, Willingham SB, Bergstralh DT. 2008. NLRs at the intersection of cell death and immunity. Nature Reviews Immunology 8: 372-379. doi: 10. 1038/nri2296.
47. Toubai T, Hou G, Mathewson N, Liu C, Wang Y, Oravecz-Wilson K, Cummings E, Rossi C, Evers R, Sun Y, Wu J, Choi SW, Fang D, Zheng P, Liu Y, Reddy P. 2014. Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice. Blood 123: 3512-3523. doi: 10. 1182/blood-2013-12-545335.
48. Tsai SY, Segovia JA, Chang TH, Morris IR, Berton MT, Tessier PA, Tardif MR, Cesaro A, Bose S. 2014. DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLOS Pathogens 10: e1003848. doi: 10. 1371/journal. ppat. 1003848.
49. Tschopp J, Schroder K. 2010. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nature Reviews Immunology 10: 210-215. doi: 10. 1038/nri2725.
50. Walter RB, Raden BW, Zeng R, Hausermann P, Bernstein ID, Cooper JA. 2008. ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2. Journal of Leukocyte Biology 83: 200-211. doi: 10. 1189/jlb. 0607388.
51. Wu Y, Liu Y. 1994. Viral induction of co-stimulatory activity on antigen-presenting cells bypasses the need for CD4+ T-cell help in CD8+ T-cell responses. Current Biology 4: 499-505. doi: 10. 1016/S0960-9822(00)00110-X.